James, Micron stock
In a report released today, Frank Louthan from Raymond James maintained a Buy rating on Equinix (EQIX – Research Report), with a price target ...
James reiterated its Strong Buy rating on Apellis Pharmaceuticals (NASDAQ:APLS), with a price target of $78.00. The stock, currently trading at $28.51, shows significant upside potential according to ...
Alliance Ground International, one of the three largest North American airport logistics providers for air cargo transport, ...
In a report released today, Stephen Boland from Raymond James maintained a Buy rating on Intact Financial Corporation (IFC – Research Report), ...
James maintained a positive outlook on Q2 Holdings (NYSE: NYSE:QTWO) shares, as analyst Alexander Sklar increased the price target from $100.00 to $110.00 while reaffirming an Outperform rating. The ...
Uncover why the promises of the second Trump administration have contractors concerned about spending and acquisition funding ...
From security to development, the wealth management firm uses the Dynatrace platform to give senior executives information on ...
The next CEO of Raymond James talks about how private equity ownership has made for some difficult marriages in wealth ...
Raymond James is seeing a beneficial shift to advisory as well as recovering M&A activity, which may continue. Read why I ...
LPL Financial welcomes a $345 million investment and planning team from Ameriprise as RayJay's employee advisor arm adds a ...
ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the Raymond James 46th Annual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback